Research Highlights

NCI awards ‘exceptional’ rating to St. Jude Comprehensive Cancer Center

For the second time in a row, the National Cancer Institute (NCI) has awarded St. Jude the highest possible rank of “exceptional” during renewal of the hospital’s Comprehensive Cancer Center grant.
Rhabdomyosarcoma discoveries move from lab to clinic

St. Jude scientists have completed the most complete analysis yet of the muscle and soft tissue tumor rhabdomyosarcoma.
St. Jude partners with University of Washington to improve knowledge worldwide

St. Jude and the Institute for Health Metrics and Evaluation at the University of Washington are partnering to advance knowledge and understanding of childhood cancer around the world.
Discovery may help some children avoid bone marrow transplantation

Researchers have solved a decades-old mystery about which mutations cause a rare, inherited bone marrow disorder. The answer may allow some children to avoid bone marrow transplantation.
Genetic counseling suggested for all childhood cancer survivors

St. Jude has completed the first genome sequencing of cancer survivors and found that 12 percent of childhood cancer survivors may have a higher risk of cancer.
Scientists identify a protein complex that shapes T cells’ destiny

Like a mentor helping medical students choose between specialties, a protein complex helps shape the destiny of developing T cells, according to St. Jude scientists.